Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Kansas City, MO
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Missoula, MT
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Missoula, MT
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Omaha, NE
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Las Vegas, NV
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Bridgewater, NJ
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Bridgewater, NJ
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Brooklyn, NY
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Cincinnati, OH
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Muskogee, OK
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Muskogee, OK
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Philadelphia, PA
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Charleston, SC
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Chattanooga, TN
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
American Fork, UT
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
American Fork, UT
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Norfolk, VA
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Seattle, WA
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Burlington, WI
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Burlington, WI
Click here to add this to my saved trials
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated:  8/14/2012
Clinical Research Facility
mi
from
Birmingham, AL
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated: 8/14/2012
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated:  8/14/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated: 8/14/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated:  8/14/2012
Clinical Research Facility
mi
from
Overland Park, KA
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated: 8/14/2012
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated:  8/14/2012
Clinical Research Facility
mi
from
Baltimore, MD
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated: 8/14/2012
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated:  8/14/2012
Clinical Research Facility
mi
from
Boston, MA
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated: 8/14/2012
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated:  8/14/2012
Clinical Research Facility
mi
from
Newark, NJ
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated: 8/14/2012
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated:  8/14/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Status: Enrolling
Updated: 8/14/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Novel Breath Test to Detect Early Stage Chronic Pancreatitis
Phase 1 Study of the Pancreatic Breath Test to Detect Early Stage Chronic Pancreatitis Utilizing the Secretin Stimulation Test
Status: Enrolling
Updated:  8/23/2012
University of Florida
mi
from
Gainesville, FL
Novel Breath Test to Detect Early Stage Chronic Pancreatitis
Phase 1 Study of the Pancreatic Breath Test to Detect Early Stage Chronic Pancreatitis Utilizing the Secretin Stimulation Test
Status: Enrolling
Updated: 8/23/2012
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Effects of Vitamin D Supplementation During Pregnancy on Clinical Outcomes and Immune Function
Assessment of Inflammatory Markers and Pregnancy Outcomes in Vitamin D-Supplemented Women at Risk of Vitamin D Deficiency: A Double-Blind, Randomized Controlled Trial
Status: Enrolling
Updated:  8/27/2012
USDA-Western Human Nutrition Research Center
mi
from
Davis, CA
Effects of Vitamin D Supplementation During Pregnancy on Clinical Outcomes and Immune Function
Assessment of Inflammatory Markers and Pregnancy Outcomes in Vitamin D-Supplemented Women at Risk of Vitamin D Deficiency: A Double-Blind, Randomized Controlled Trial
Status: Enrolling
Updated: 8/27/2012
USDA-Western Human Nutrition Research Center
mi
from
Davis, CA
Click here to add this to my saved trials
Effects of Vitamin D Supplementation During Pregnancy on Clinical Outcomes and Immune Function
Assessment of Inflammatory Markers and Pregnancy Outcomes in Vitamin D-Supplemented Women at Risk of Vitamin D Deficiency: A Double-Blind, Randomized Controlled Trial
Status: Enrolling
Updated:  8/27/2012
UC Davis Medical Center Obstetrics & Gynecology
mi
from
Sacramento, CA
Effects of Vitamin D Supplementation During Pregnancy on Clinical Outcomes and Immune Function
Assessment of Inflammatory Markers and Pregnancy Outcomes in Vitamin D-Supplemented Women at Risk of Vitamin D Deficiency: A Double-Blind, Randomized Controlled Trial
Status: Enrolling
Updated: 8/27/2012
UC Davis Medical Center Obstetrics & Gynecology
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration
A Phase 4, Pilot, Open-label Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration
Status: Enrolling
Updated:  8/29/2012
Friends Research Institute
mi
from
Baltimore, MD
A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration
A Phase 4, Pilot, Open-label Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration
Status: Enrolling
Updated: 8/29/2012
Friends Research Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Prontosan Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients
A Randomized, Double-Blind Exploratory Pilot Study Comparing Prontosan(TM) Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients
Status: Enrolling
Updated:  8/30/2012
University of California at San Diego
mi
from
San Diego, CA
Prontosan Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients
A Randomized, Double-Blind Exploratory Pilot Study Comparing Prontosan(TM) Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients
Status: Enrolling
Updated: 8/30/2012
University of California at San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Prontosan Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients
A Randomized, Double-Blind Exploratory Pilot Study Comparing Prontosan(TM) Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients
Status: Enrolling
Updated:  8/30/2012
University of Illinois, Chicago
mi
from
Chicago, IL
Prontosan Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients
A Randomized, Double-Blind Exploratory Pilot Study Comparing Prontosan(TM) Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients
Status: Enrolling
Updated: 8/30/2012
University of Illinois, Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated:  8/30/2012
Clinical Research Facility
mi
from
Birmingham, AL
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated: 8/30/2012
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated:  8/30/2012
Clinical Research Facility
mi
from
Phoenix, AZ
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated: 8/30/2012
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated:  8/30/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated: 8/30/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated:  8/30/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated: 8/30/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated:  8/30/2012
Clinical Research Facility
mi
from
Overland Park, KA
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated: 8/30/2012
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated:  8/30/2012
Clinical Research Facility
mi
from
Metairie, LA
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated: 8/30/2012
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated:  8/30/2012
Clinical Research Facility
mi
from
Boston, MA
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated: 8/30/2012
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated:  8/30/2012
Clinical Research Facility
mi
from
Jackson, MS
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated: 8/30/2012
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated:  8/30/2012
Clinical Research Facility
mi
from
Albuquerque, NM
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated: 8/30/2012
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated:  8/30/2012
Clinical Research Facility
mi
from
Ashville, NC
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated: 8/30/2012
Clinical Research Facility
mi
from
Ashville, NC
Click here to add this to my saved trials
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated:  8/30/2012
Clinical Research Facility
mi
from
Chattanooga, TN
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated: 8/30/2012
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated:  8/30/2012
Clinical Research Facility
mi
from
Dallas, TX
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated: 8/30/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated:  8/30/2012
Clinical Research Facility
mi
from
Norfolk, VA
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated: 8/30/2012
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
A Phase II Study of Capecitabine, Carboplatin, and Bevacizumab for Metastatic or Unresectable Gastroesophageal Junction and Gastric Adenocarcinoma
Status: Enrolling
Updated:  9/3/2012
Stanford University School of Medicine
mi
from
Stanford, CA
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
A Phase II Study of Capecitabine, Carboplatin, and Bevacizumab for Metastatic or Unresectable Gastroesophageal Junction and Gastric Adenocarcinoma
Status: Enrolling
Updated: 9/3/2012
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Compliance of Compression Therapy in Healed Venous Ulcerations
Compliance of Compression Therapy in Healed Venous Ulcerations
Status: Enrolling
Updated:  9/4/2012
Richmond Medical Center (University Hospitals of Cleveland)
mi
from
Richmond Heights, OH
Compliance of Compression Therapy in Healed Venous Ulcerations
Compliance of Compression Therapy in Healed Venous Ulcerations
Status: Enrolling
Updated: 9/4/2012
Richmond Medical Center (University Hospitals of Cleveland)
mi
from
Richmond Heights, OH
Click here to add this to my saved trials
Pilot Study of GS-6624 in the Treatment of Liver Fibrosis
A Phase 2a, Pilot, Open-Label Trial Evaluating the Safety, Tolerability and Pharmacodynamic Effects of GS-6624 in Subjects With Fibrosis of the Liver
Status: Enrolling
Updated:  9/5/2012
Weill Cornell Medical College/NewYork-Presbyterian Hospital
mi
from
New York, NY
Pilot Study of GS-6624 in the Treatment of Liver Fibrosis
A Phase 2a, Pilot, Open-Label Trial Evaluating the Safety, Tolerability and Pharmacodynamic Effects of GS-6624 in Subjects With Fibrosis of the Liver
Status: Enrolling
Updated: 9/5/2012
Weill Cornell Medical College/NewYork-Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
The Clinical Utility of Overtube Use at the Time of Endoscopy
The Clinical Utility of Overtube Use at the Time of Endoscopy
Status: Enrolling
Updated:  9/14/2012
Shands at UF
mi
from
Gainesville, FL
The Clinical Utility of Overtube Use at the Time of Endoscopy
The Clinical Utility of Overtube Use at the Time of Endoscopy
Status: Enrolling
Updated: 9/14/2012
Shands at UF
mi
from
Gainesville, FL
Click here to add this to my saved trials
Phase III Trial of Coenzyme Q10 in Mitochondrial Disease
Status: Enrolling
Updated:  9/17/2012
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Phase III Trial of Coenzyme Q10 in Mitochondrial Disease
Status: Enrolling
Updated: 9/17/2012
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Phase III Trial of Coenzyme Q10 in Mitochondrial Disease
Status: Enrolling
Updated:  9/17/2012
Case Western Reserve Univ
mi
from
Cleveland, OH
Phase III Trial of Coenzyme Q10 in Mitochondrial Disease
Status: Enrolling
Updated: 9/17/2012
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
University of Arizona Arthritis Center
mi
from
Tucson, AZ
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
University of Arizona Arthritis Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
UCLA Medical School - Rheumatology Division Rehabilitation Center
mi
from
Los Angeles, CA
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
UCLA Medical School - Rheumatology Division Rehabilitation Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Arthritis and Rheumatic Disease Specialties
mi
from
Aventura, FL
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Arthritis and Rheumatic Disease Specialties
mi
from
Aventura, FL
Click here to add this to my saved trials